ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

BET Bromodomain Inhibition Reverses CDK4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer via Induction of miR-34a-5p.

Renyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.